E-Paper

UAE

Life and Living

World

Opinion

Business

Sports

Entertainment

Dubai World Cup

lifestyle

Travel

Reviews

Brands

Supplements

KT Events

KT APPDOWNLOAD

UAE asks Pfizer to update side effects of 2 drugs

Top Stories

UAE announces 2-month grace period for residence visa violators

UAE announces fee refund for tax service charges from August 1

Paid parking in Dubai: Residents face up to Dh4,000 extra yearly costs when new rates kick in
UAE asks Pfizer to update side effects of 2 drugs

Dubai - UAE has advised the company to update the information leaflet.

By Web Report

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Wed 20 Mar 2019, 3:36 PM

Last updated: Wed 20 Mar 2019, 6:05 PM

The Ministry of Health and Prevention has issued an advisory on the use of two medicines produced by the pharmaceuticals giant, Pfizer.
Also read: Talcum powder brand warning issued in UAE
According to the ministry, the company updated the list of side effects caused by the two medicines used for treating rheumatoid arthritis, Psoriatic arthritis and Ulcerative colitis.
The medicines, (Xeljanz 5mg) and (Xeljanz XR 11mg), distributed locally by Gulf Drug, have the active substance Tofacitinib that in high doses increases the risk of forming blood clots in the lungs.
Also read: UAE issues 'increased risk of death' advisory for 4 drugs
The ministry ordered the manufacturing company to clearly mention the risks in the patient information leaflet, adding that the aforementioned medicines are safe and will not be banned in the local market.
Additionally, the ministry urged people using the drug to report any side effects from using these two medicines.
Contact the ministry via email: pv@moh.gov.ae


More news from